MX2013005581A - Sistema terapeutico transdermico para la administracion de una sustancia activa. - Google Patents
Sistema terapeutico transdermico para la administracion de una sustancia activa.Info
- Publication number
- MX2013005581A MX2013005581A MX2013005581A MX2013005581A MX2013005581A MX 2013005581 A MX2013005581 A MX 2013005581A MX 2013005581 A MX2013005581 A MX 2013005581A MX 2013005581 A MX2013005581 A MX 2013005581A MX 2013005581 A MX2013005581 A MX 2013005581A
- Authority
- MX
- Mexico
- Prior art keywords
- active substance
- administering
- transdermal therapeutic
- therapeutic system
- layer
- Prior art date
Links
- 239000013543 active substance Substances 0.000 title abstract 4
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- 239000010410 layer Substances 0.000 abstract 4
- 239000004821 Contact adhesive Substances 0.000 abstract 1
- 229920002367 Polyisobutene Polymers 0.000 abstract 1
- 239000012790 adhesive layer Substances 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229920001083 polybutene Polymers 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Inorganic Chemistry (AREA)
- Psychiatry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se refiere a un sistema terapéutico transdérmico para la administración de una sustancia activa a través de la piel, dicho sistema siendo adecuado para un período de aplicación de por lo menos tres días,, que comprende las capas dispuestas en el orden siguiente con respecto una a la otra: a) una capa de cubierta, b) una capa de principio activo que comprende una matriz polimérica que contiene la sustancia activa, c) una capa adhesiva que comprende un adhesivo de contacto, que consiste en una mezcla de uno o más poliisobutilenos y uno o más polibutenos, y d) una capa de desprendimiento.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10194968.3A EP2468274B1 (de) | 2010-12-14 | 2010-12-14 | Transdermales therapeutisches System zur Verabreichung eines Wirkstoffs |
| PCT/EP2011/072812 WO2012080365A1 (de) | 2010-12-14 | 2011-12-14 | Transdermales therapeutisches system zur verabreichung eines wirkstoffs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2013005581A true MX2013005581A (es) | 2013-08-26 |
| MX345344B MX345344B (es) | 2017-01-26 |
Family
ID=43836835
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2013005581A MX345344B (es) | 2010-12-14 | 2011-12-14 | Sistema terapéutico transdérmico para la administración de una sustancia activa. |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US10660863B2 (es) |
| EP (2) | EP2468274B1 (es) |
| JP (1) | JP6043296B2 (es) |
| KR (1) | KR101842309B1 (es) |
| CN (3) | CN103269698B (es) |
| AU (2) | AU2011343363B2 (es) |
| BR (1) | BR112013014616B1 (es) |
| CA (2) | CA3065240C (es) |
| CY (2) | CY1116638T1 (es) |
| DK (2) | DK2468274T3 (es) |
| EA (1) | EA026520B1 (es) |
| ES (2) | ES2545094T3 (es) |
| HK (1) | HK1243336A1 (es) |
| HR (2) | HRP20201880T1 (es) |
| HU (2) | HUE027916T2 (es) |
| LT (1) | LT2651410T (es) |
| MX (1) | MX345344B (es) |
| MY (1) | MY183873A (es) |
| PL (2) | PL2468274T3 (es) |
| PT (2) | PT2468274E (es) |
| RS (2) | RS54173B1 (es) |
| SI (2) | SI2468274T1 (es) |
| SM (2) | SMT202000638T1 (es) |
| WO (1) | WO2012080365A1 (es) |
| ZA (1) | ZA201303965B (es) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102012000369A1 (de) * | 2012-01-11 | 2013-07-11 | Alfred E. Tiefenbacher (Gmbh & Co. Kg) | Transdermales therapeutisches System mit Cholinesterase-Hemmer |
| DE102012016317A1 (de) | 2012-08-14 | 2014-02-20 | Jenabatteries GmbH | Redox-Flow-Zelle zur Speicherung elektrischer Energie |
| WO2014028049A1 (en) * | 2012-08-15 | 2014-02-20 | Dow Corning Corporation | Multi - layer transdermal drug delivery system |
| WO2014111790A2 (en) * | 2013-01-15 | 2014-07-24 | Zydus Technologies Limited | Stable transdermal pharmaceutical drug delivery system comprising rivastigmine |
| US20240082065A1 (en) * | 2016-07-08 | 2024-03-14 | Moteah Williams | Waterproof and transparent wound barrier and method of manufacturing same |
| JP6864968B2 (ja) | 2016-08-22 | 2021-04-28 | 救急薬品工業株式会社 | 貼付剤 |
| JP7193863B2 (ja) * | 2017-07-19 | 2022-12-21 | 帝國製薬株式会社 | リバスチグミン含有経皮吸収型製剤 |
| DE102018120505A1 (de) * | 2017-10-20 | 2019-04-25 | Amw Gmbh | Verhinderung der Kristallisation von Wirkstoffen in transdermalen Darreichungssystemen |
| DE102017127433A1 (de) * | 2017-11-21 | 2019-05-23 | Lts Lohmann Therapie-Systeme Ag | TTS auf Basis von klebenden Weichmacher-Polymer-Matrices |
| US20210038532A1 (en) * | 2018-03-13 | 2021-02-11 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system comprising a silicone acrylic hybrid polymer |
| CN111885992B (zh) * | 2018-05-17 | 2023-12-08 | 松下知识产权经营株式会社 | 生物体贴附用选择性透过膜、透皮吸收套件和美容方法 |
| ES2923891T3 (es) * | 2018-08-08 | 2022-10-03 | Danapak Flexibles As | Películas y láminas mejoradas para usarse en el envase de compuestos reactivos |
| KR102823139B1 (ko) | 2018-08-31 | 2025-06-19 | 에스케이케미칼 주식회사 | 장기 투여용 리바스티그민 패취 |
| KR102710072B1 (ko) | 2018-08-31 | 2024-09-24 | 에스케이케미칼 주식회사 | 장기 투여용 리바스티그민 패취 |
| JP7549642B2 (ja) * | 2019-07-09 | 2024-09-11 | エルテーエス ローマン テラピー－ジステーメ アーゲー | アクリルポリマーを含む活性剤含有層及びシリコーンゲル接着剤を含む皮膚接触層を含む経皮治療システム |
| CN113616625B (zh) * | 2021-08-26 | 2023-05-30 | 大连科翔科技开发有限公司 | 一种卡巴拉汀的长效透皮贴剂 |
| DE102021128912A1 (de) * | 2021-11-05 | 2023-05-11 | Lts Lohmann Therapie-Systeme Ag. | Okklusives pflaster mit flexibler backing |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL195004C (nl) | 1987-03-04 | 2003-11-04 | Novartis Ag | Fenylcarbamaat bevattend farmaceutisch preparaat. |
| WO1994004109A1 (en) * | 1992-08-25 | 1994-03-03 | Cygnus Therapeutic Systems | Printed transdermal drug delivery device |
| JPH0912448A (ja) * | 1995-04-28 | 1997-01-14 | Read Chem Kk | 薬物放出制御型経皮吸収製剤 |
| GB9800526D0 (en) * | 1998-01-12 | 1998-03-11 | Ciba Geigy Ag | Organic compounds |
| US6348210B1 (en) * | 1998-11-13 | 2002-02-19 | Alza Corporation | Methods for transdermal drug administration |
| DE19918106A1 (de) * | 1999-04-22 | 2000-10-26 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit neutralisierten Acrylathaftklebern |
| DE10033853A1 (de) | 2000-07-12 | 2002-01-31 | Hexal Ag | Transdermales therapeutisches System mit hochdispersem Siliziumdioxid |
| DE10103860B4 (de) * | 2001-01-30 | 2004-12-23 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System für die Verabreichung carboxylgruppenhaltiger, nichtsteroidaler Antiphlogistika, sowie Verfahren zu seiner Herstellung |
| DE10141652B4 (de) | 2001-08-24 | 2011-04-07 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System auf der Basis von Polyacrylat-Haftklebern ohne funktionelle Gruppen und seine Verwendung |
| DE10141650C1 (de) * | 2001-08-24 | 2002-11-28 | Lohmann Therapie Syst Lts | Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen |
| US8252319B2 (en) * | 2004-10-21 | 2012-08-28 | Durect Corporation | Transdermal delivery system for sufentanil |
| ATE471146T1 (de) * | 2004-10-21 | 2010-07-15 | Durect Corp | Transdermale verabreichungssysteme |
| TWI389709B (zh) * | 2005-12-01 | 2013-03-21 | Novartis Ag | 經皮治療系統 |
| WO2007076862A1 (en) * | 2005-12-30 | 2007-07-12 | Coloplast A/S | A layered adhesive construct having a mouldable layer as skin contact surface |
| CN101304735A (zh) * | 2006-01-12 | 2008-11-12 | Lts勒曼治疗系统股份公司 | 用于挥发性和/或热不稳定的物质的经皮治疗体系 |
| CN101460156B (zh) * | 2006-05-08 | 2011-06-08 | 帝国制药株式会社 | 抗痴呆药的经皮吸收制剂 |
| US9248104B2 (en) | 2006-08-17 | 2016-02-02 | Core Tech Solutions, Inc. | Transdermal methods and systems for treating Alzheimer's disease |
| DE102006054731B4 (de) * | 2006-11-21 | 2013-02-28 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System zur Verabreichung des Wirkstoffs Buprenorphin und Verwendung desselben in der Schmerztherapie |
| EP2167001A4 (en) * | 2007-07-10 | 2012-10-31 | Agile Therapeutics Inc | DEVICE FOR THE DERIVED ULTRASONIC WELDING |
| WO2009026135A2 (en) * | 2007-08-17 | 2009-02-26 | Alza Corporation | Controlled transdermal bisoprolol delivery system |
| US9155725B2 (en) * | 2008-02-27 | 2015-10-13 | Hisamitsu Pharmaceutical Co., Inc. | Adhesive skin patch and packaged product |
| US20090291127A1 (en) * | 2008-05-21 | 2009-11-26 | Jianye Wen | Transdermal anti-dementia active agent formulations and methods for using the same |
| JP2010126450A (ja) * | 2008-11-25 | 2010-06-10 | Lintec Corp | 経皮吸収貼付剤 |
| PT2515886T (pt) * | 2009-12-22 | 2018-05-23 | Luye Pharma Ag | Sistema terapêutico transdermal para a administração de rivastigmina ou de seus derivados |
-
2010
- 2010-12-14 DK DK10194968.3T patent/DK2468274T3/en active
- 2010-12-14 PL PL10194968T patent/PL2468274T3/pl unknown
- 2010-12-14 SI SI201031006T patent/SI2468274T1/sl unknown
- 2010-12-14 PT PT101949683T patent/PT2468274E/pt unknown
- 2010-12-14 HU HUE10194968A patent/HUE027916T2/en unknown
- 2010-12-14 EP EP10194968.3A patent/EP2468274B1/de active Active
- 2010-12-14 RS RS20150562A patent/RS54173B1/sr unknown
- 2010-12-14 ES ES10194968.3T patent/ES2545094T3/es active Active
-
2011
- 2011-12-14 JP JP2013543774A patent/JP6043296B2/ja active Active
- 2011-12-14 CN CN201180059614.1A patent/CN103269698B/zh active Active
- 2011-12-14 KR KR1020137016047A patent/KR101842309B1/ko active Active
- 2011-12-14 HU HUE11799413A patent/HUE052137T2/hu unknown
- 2011-12-14 EA EA201300704A patent/EA026520B1/ru not_active IP Right Cessation
- 2011-12-14 RS RS20201478A patent/RS61155B1/sr unknown
- 2011-12-14 DK DK11799413.7T patent/DK2651410T3/da active
- 2011-12-14 EP EP11799413.7A patent/EP2651410B1/de active Active
- 2011-12-14 LT LTEP11799413.7T patent/LT2651410T/lt unknown
- 2011-12-14 PL PL11799413T patent/PL2651410T3/pl unknown
- 2011-12-14 CN CN201710451001.1A patent/CN107412202A/zh active Pending
- 2011-12-14 HR HRP20201880TT patent/HRP20201880T1/hr unknown
- 2011-12-14 CA CA3065240A patent/CA3065240C/en active Active
- 2011-12-14 AU AU2011343363A patent/AU2011343363B2/en active Active
- 2011-12-14 SM SM20200638T patent/SMT202000638T1/it unknown
- 2011-12-14 MX MX2013005581A patent/MX345344B/es active IP Right Grant
- 2011-12-14 ES ES11799413T patent/ES2836483T3/es active Active
- 2011-12-14 PT PT117994137T patent/PT2651410T/pt unknown
- 2011-12-14 SI SI201131933T patent/SI2651410T1/sl unknown
- 2011-12-14 US US13/994,242 patent/US10660863B2/en active Active
- 2011-12-14 BR BR112013014616-8A patent/BR112013014616B1/pt active IP Right Grant
- 2011-12-14 MY MYPI2013001975A patent/MY183873A/en unknown
- 2011-12-14 CA CA2817461A patent/CA2817461C/en active Active
- 2011-12-14 WO PCT/EP2011/072812 patent/WO2012080365A1/de not_active Ceased
- 2011-12-14 CN CN202110438860.3A patent/CN113244199A/zh active Pending
-
2013
- 2013-05-30 ZA ZA2013/03965A patent/ZA201303965B/en unknown
-
2015
- 2015-07-31 SM SM201500184T patent/SMT201500184B/xx unknown
- 2015-08-19 HR HRP20150881TT patent/HRP20150881T1/hr unknown
- 2015-08-25 CY CY20151100738T patent/CY1116638T1/el unknown
-
2017
- 2017-08-11 AU AU2017213569A patent/AU2017213569B2/en active Active
-
2018
- 2018-02-28 HK HK18102858.7A patent/HK1243336A1/zh unknown
-
2020
- 2020-04-28 US US16/860,210 patent/US20200289426A1/en not_active Abandoned
- 2020-11-25 CY CY20201101121T patent/CY1123712T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX345344B (es) | Sistema terapéutico transdérmico para la administración de una sustancia activa. | |
| MY163809A (en) | Transdermal drug delivery system containing donepezil | |
| IN2012DN01225A (es) | ||
| MX2009012273A (es) | Dispositivos de suministro transd?rmico que aseguran la liberaci?n mejorada de un principio activo a trav?s de una interfaz biol?gica. | |
| WO2011076621A3 (de) | Transdermales therapeutisches system zur verabreichung von rivastigmin oder dessen derivaten | |
| WO2012124966A3 (ko) | 펜타닐 경피 패치제 | |
| BR112012024835A2 (pt) | adesivo de distribuição transdérmica | |
| WO2011022199A8 (en) | Multi-layer transdermal patch | |
| UA114101C2 (xx) | Трансдермальна терапевтична система для введення фентанілу або його аналога | |
| WO2014028396A3 (en) | Therapeutic elastic tape | |
| MX382132B (es) | Sistema terapeutico transdermico que contiene asenapina y polisiloxano o poliisobutileno | |
| PH12012501523A1 (en) | Dental strip for administration of oral treatment | |
| BR112012001349B8 (pt) | processo livre de solvente para produzir uma composição adesiva | |
| NZ709521A (en) | Transdermal dosage form for low-melting point active agent | |
| MX2014002215A (es) | Sistema terapeutico transdermico para clorhidrato de acido 5-aminolevulinico. | |
| WO2010111533A3 (en) | Transdermal delivery of pkc modulatory peptides through microporated skin | |
| EA201300648A1 (ru) | Трансдермальная терапевтическая система (tts), содержащая ротиготин | |
| WO2016149077A3 (en) | Fentanyl transdermal delivery system | |
| IN2014CN02984A (es) | ||
| WO2011066970A3 (de) | Transdermales therapeutisches system für die verabreichung von peptiden | |
| EA201490390A1 (ru) | Вспомогательное средство для накладывания | |
| WO2012111996A3 (ko) | 갈란타민 또는 그의 염을 함유하는 경피흡수제제 | |
| MX2015010967A (es) | Formulaciones transdermicas de laquinimod. | |
| NZ595549A (en) | Transdermal therapeutic system containing nicotine | |
| WO2012009640A3 (en) | B cell depletion for central nervous system injuries and methods and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |